Most of the proteins in the Ras-family proteins, including Ras, Rap and TC21, have been reported to be strong inhibitors of skeletal myogenesis. Here we show that R-Ras, another member of this family, promotes terminal dierentiation of C2C12 skeletal myoblasts. In contrast to Ras, which induced a markedly transformed phenotype of C2C12 cells, an activated mutant of R-Ras (R-Ras Q87L ) did not exhibit any inhibitory eect on the dierentiation of C2C12 cells, but enhanced the formation of multinucleated myotubes. Although R-Ras Q87L showed little eect on induction of two muscle-speci®c proteins, creatine kinase and myogenin, it prevented cell death during myoblast dierentiation, probably through Akt activation and Bcl-x L induction. Motility of C2C12 cells, which may be involved in fusion of myoblasts, was also stimulated by R-Ras
Introduction
R-Ras is a low-molecular-weight GTP-binding protein which shares about 50% homology with Ras isoforms (H-, K-and N-Ras) . Like the other GTP-binding proteins (Kaziro et al., 1991; Lowy and Willumsen, 1993) , R-Ras functions as a molecular switch, cycling between the active GTPbound state and the inactive GDP-bound state. RRas has been reported to modulate cell adhesion to extracellular matrix proteins through integrins (Zhang et al., 1996) , apoptosis (Wang et al., 1995; Suzuki et al., 1997) , cell migration and invasion (Keely et al., 1999) . On the other hand, unlike Ras, R-Ras can induce neither transformation of Rat1 cells, DNA synthesis in Swiss 3T3 cells, neuronal dierentiation of pheochromocytoma (PC)-12 cells, nor germinal vesicle breakdown in Xenopus oocytes Rey et al., 1994) . Therefore, in spite of its similarity to Ras, R-Ras seems to play a distinct role from Ras.
Skeletal muscle dierentiation is characterized by coordinated expression of muscle-speci®c genes, exit from the cell cycle, and formation of multinucleated myotubes. It has been reported that several factors regulate skeletal myogenesis (Olson, 1992; Florini et al., 1996) : Insulin-like growth factor-1 and -2 positively regulate the terminal dierentiation of myoblast, while transforming growth factor-b, ®bro-blast growth factor, and bone morphogenetic protein prevent it. The dierentiation is also inhibited by expression of several oncogenes such as myc, fos, jun and ras (Olson, 1992) . It is well-established that oncogenic Ras inhibits skeletal myogenesis, probably through mimicking signaling events exerted by growth factors Payne et al., 1987; Konieczny et al., 1989; Lassar et al., 1989) . In addition to Ras, two other Ras-family proteins, Rap1 and TC21, also block skeletal myogenesis (Pizon et al., 1999; Graham et al., 1999) . No studies, on the other hand, have reported the role of R-Ras in dierentiation of myoblasts. Here we examined the eect of R-Ras on skeletal myogenesis utilizing C2C12 skeletal myoblasts as an in vitro model system.
Results

An activated mutant of R-Ras promotes myogenic differentiation of C2C12 cells
In the`growth medium', C2C12 cells grow and are prevented from dierentiation, while they dierentiate into multinucleated myotubes when cultured in the `dierentiation medium' that contains low mitogen (see Materials and methods). To examine the potential role of R-Ras in C2C12 dierentiation, we established C2C12 stable clones that inducibly express an activated mutant of R-Ras (R-Ras Q87L ) in the presence of isopropyl-b-D-thiogalactoside (IPTG). Of several established clones, we used one clone designated C2-R-Ras(L3) for further studies, because this clone dierentiated as well as its parental C2C12 cells in the dierentiation medium. In C2-R-Ras(L3) cells, expression of R-Ras Q87L was observed 1 day after addition of IPTG to the growth medium ( Figure 1a) . To compare the phenotype of R-Ras with Ras, we also established a clone, C2-HRas(V1), which expresses an activated mutant of HRas (H-Ras G12V ) in an IPTG-dependent manner ( Figure 1a) . Figure 1b shows the morphology of C2-RRas(L3) and C2-H-Ras(V1) cells, either growing or being dierentiated. In the growth medium, IPTG-induced expression of R-Ras did not aect cell morphology, while that of H-Ras resulted in refractile and phase bright appearance as previously described . When cells were allowed to be dierentiated in the dierentiation medium without IPTG, both clones formed multinucleated myotubes as observed in parental C2C12 cells. C2-H-Ras(V1) cells treated with IPTG, however, failed to form myotubes and exhibited strikingly transformed morphology. In IPTG-treated C2-R-Ras(L3) cells, in contrast, myotube formation was signi®cantly enhanced. Similar results were obtained with another clone expressing R-Ras Q87L (data not shown). . C2-R-Ras(L3) and C2-H-Ras(V1) cells were cultured for 1 day in the growth medium in the presence or absence of IPTG (5 mM). Then cells were lysed, and the lysates (25 mg of protein) were subjected to Western blotting analysis with anti-R-Ras (1 : 1000) and anti-H-Ras (1 : 100) antibodies. (b) Eect of R-Ras Q87L and H-Ras G12V on myotube formation. C2-RRas(L3) cells and C2-H-Ras(V1) cells were pretreated with or without IPTG (5 mM) for 12 h and cultured for 1 day in the growth medium (GM) or 5 days in the dierentiation medium (DM) with or without IPTG (5 mM). (c) Eect of R-Ras Q87L and H-Ras To con®rm the promotion of myogenic dierentiation by R-Ras, we measured the activity of creatine kinase, a typical marker enzyme for myogenesis. In the absence of IPTG, the creatine kinase activity (per dish) began to increase about 1 day after being switched to the dierentiation medium ( Figure 1c , open square). When C2-R-Ras(L3) cells were cultured with IPTG, the increase of kinase activity was signi®cantly larger than the case without IPTG (left panel). By contrast, induction of the creatine kinase activity in C2-H-Ras(V1) cells was strongly inhibited by IPTG treatment (right panel). From these results, it was concluded that R-Ras, but not H-Ras, enhances the terminal dierentiation of C2C12 cells.
In addition, we noticed that IPTG-treated C2-RRas(L3) cells formed thicker tubes than untreated C2-R-Ras(L3) cells (Figure 1b) , suggesting the possibility that R-Ras may promote the fusion of myoblasts. Thus, we measured the fusion index, the ratio of the nuclei in multinucleated myotubes to total nuclei (Figure 1d ). When C2-R-Ras(L3) cells were dierentiated in the absence of IPTG, the fusion index was about 30%, which increased to over 40% in the presence of IPTG. The results suggest that R-Ras raises the fusion eciency of myoblasts.
R-Ras shows no effect on induction of creatine kinase and myogenin
The myogenic dierentiation is accompanied by coordinated expression of a variety of musclespeci®c proteins including creatine kinase, myogenin and myosin heavy chain. To determine if R-Ras stimulates dierentiation of C2C12 myoblasts through upregulation of the muscle-speci®c proteins, we examined the expression of creatine kinase and myogenin in C2-R-Ras(L3) cells. Although the creatine kinase activity per dish was enhanced by R-Ras Q87L expression (Figure 1c ), the creatine kinase activity per protein was hardly aected by IPTG treatment (Figure 2a ), suggesting that R-Ras cannot increase the level of creatine kinase in each cell. As for myogenin, Western blotting analysis showed that myogenin was induced 12 h after transferring C2-RRas(L3) cells to the dierentiation medium ( Figure  2b) . However, the level of myogenin expression was not augmented by IPTG treatment. These results suggest that R-Ras has little eect on the induction of muscle-speci®c proteins and raise the possibility that R-Ras-induced increase of creatine kinase activity (per dish) may be due to the increased number of dierentiated myoblasts.
R-Ras inhibits cell death upon myogenic differentiation
Previous reports had shown that myogenic dierentiation accompanies loss of a signi®cant fraction of myoblasts by apoptosis (Fimia et al., 1996; Wang and Walsh, 1996; Wang et al., 1997) . Since we have demonstrated that R-Ras has an antiapoptotic property in BaF3 cells (Suzuki et al., 1997) , we next examined whether R-Ras can suppress cell death during myogenic dierentiation of C2C12 cells. The IPTG-treated or untreated C2-R-Ras(L3) cells were allowed to dierentiate for 2 days in the dierentiation medium, and the cell nuclei were stained with Hoechst 33342. Dead cells that exhibited chromatin condensation, a hallmark of apoptosis, were then counted microscopically. As a result, the myoblasts expressing R-Ras Q87L showed an approximately 30% reduction of cell death over the control cells (Figure 3a) . Correspondingly, when we counted the number of C2-R-Ras(L3) cells at day 2 after the onset of dierentiation, the number of IPTG-treated cells was larger than that of untreated cells (Figure 3b ). Thus, it is likely that R-Ras increased the number of dierentiated myoblasts by inhibition of their apoptosis, which resulted in the increase of creatine kinase activity per dish ( Figure 1c ). Q87L on myogenin expression. Lysates were prepared as described above and were resolved by 13% SDS ± PAGE. Myogenin expression was analysed by Western blotting analysis using anti-myogenin antibody (1 : 1000)
We have previously shown that Akt/protein kinase B and Bcl-x L are involved in R-Ras-mediated suppression of cell death in BaF3 cells (Suzuki et al., 1998) . Therefore we tested whether these molecules also participate in R-Ras-mediated survival in myoblasts. Western blotting analysis utilizing anti-phospho Akt (Ser 473 ) showed that Akt phosphorylation at Ser 473 , a hallmark of Akt activation (Alessi et al., 1996) , was promoted in R-Ras Q87L -expressing C2-RRas(L3) cells (Figure 3c ). As for Bcl-x L , in the absence of R-Ras Q87L expression, Bcl-x L protein was poorly expressed in proliferating myoblasts (at time 0), and was signi®cantly induced under dierentiating condition (Figure 3d ). On the other hand, in the presence of R-Ras Q87L expression, Bcl-x L expression was observed to some extent even in proliferating conditions and reached a plateau faster than the control cells during dierentiation. These data suggest that R-Ras maintains the survival of dierentiating myoblasts through Akt activation and the induction of Bcl-x L expression.
R-Ras promotes motility of C2C12 cells
Recently, it has been reported that R-Ras induces an increase of migration of epithelial cells on collagen (Keely et al., 1999) . Since cell migration is possibly involved in myoblast fusion, we investigated the eect 
R-Ras is involved in the program of myogenesis
Since we observed that the activated mutant of RRas enhanced myogenic dierentiation of C2C12 cells, we next investigated whether R-Ras is indeed involved in the program of skeletal myogenesis in C2C12 cells. It has been reported that R-ras mRNA is highly expressed in muscle (Saez et al., 1994) . Thus, we compared the expression level of R-Ras protein among a series of cell lines. Cell extracts from ®broblasts, epithelial cells, myoblasts, lymphocytes, and neuroblasts were immunoblotted with anti-R-Ras antibody (Figure 5a ). R-Ras was highly expressed in dierentiating myoblasts (C2C12 and L6) as compared to the other cell lines, suggesting that R-Ras may be important for the dierentiation of myoblasts.
We investigated whether R-Ras is activated during terminal dierentiation of C2C12 cells into myotubes. We performed R-Ras´GTP precipitation assay utilizing glutathione S-transferase-fused Ras-binding domain of PI3K (GST-PI3K-RBD) to detect the GTP-bound form of R-Ras in C2C12 cells. RRas´GTP was not detected in proliferating C2C12 cells (day 0), whereas a transient accumulation of RRas´GTP was observed in dierentiating cultures (Figure 5b ). In addition, the expression of R-Ras was increased on dierentiation (Figure 5c ). These results indicate the possibility that R-Ras plays a positive role in myogenic dierentiation of C2C12 cells.
In an attempt to ascertain that R-Ras is required for dierentiation of C2C12 cells, we transfected cDNA of R-Ras GAP that speci®cally inactivates R-Ras (Yamamoto et al., 1995) . The eect of RRas GAP on myogenic dierentiation was examined by measuring the creatine kinase activity (per dish), which re¯ects the number of dierentiated cells as judged from the results of the experiments with the activated mutant of R-Ras. As shown in Figure 5d , creatine kinase activity decreased in R-Ras GAPtransfected C2C12 cells. Since the eciency of transfection, which was estimated by transfection of expression vector encoding green¯uorescent protein, was about 50% (data not shown), the results suggest that expression of R-Ras GAP results in more than 50% reduction in the number of dierentiated cells. It has been reported that Ras activity is downregulated in dierentiated myotubes (Gutmann et al., 1994) , and we could not observe any inhibitory eect of a dominant-negative mutant of H-Ras on the C2C12 dierentiation (data not shown). Therefore, it is unlikely that our observations are the consequence of non-speci®c inhibition of Ras by R-Ras GAP. These results, taken together, suggest that R-Ras is both involved in and required for skeletal myogenesis of C2C12 myoblasts.
Discussion
Previous reports have shown that most Ras-family GTP-binding proteins, such as H-Ras, N-Ras, Rap1 and TC21, inhibit skeletal muscle dierentiation Payne et al., 1987; Konieczny et al., 1989; Lassar et al., 1989; Pizon et al., 1999; Graham et al., 1999) . The Ras-regulated signaling pathways leading to the inhibition of myogenesis are being clari®ed. Ras activates at least three classes of eectors (Campbell et al., 1998) , Raf (A-Raf, B-Raf and Raf-1), Ral-GEF (Ral-GDS, Rlf and Rgl) and PI3K. It has been reported that the expression of the activated mutant of Raf (Raf-CAAX) inhibits myo®ber formation, and that of Ral-GDS (Ral-GDS-CAAX) inhibits the expression of musclespeci®c genes (Ramocki et al., 1997 (Ramocki et al., , 1998 . On the other hand, the expression of activated mutant of PI3K markedly promotes dierentiation, and PI3K-speci®c inhibitors interfere with it (Kaliman et al., 1996; Jiang et al., 1998) . In addition, Akt, a downstream molecule of PI3K, has been reported to enhance terminal dierentiation of myoblasts (Jiang et al., 1999) . Taken together, it is likely that activation of Raf and Ral-GEF results in the inhibition of myogenesis, while that of PI3K leads to its promotion. When the activating abilities of these three eectors among Ras-family proteins are compared, Ras can activate all of the eectors (Campbell et al., 1998) , Rap1 activates B-Raf and Ral-GEFs (Ohtsuka et al., 1996; Kishida et al., 1997; Zwartkruis et al., 1998) , and TC21 activates B-Raf and Raf-1 (RosaÂ rio et al., 1999) . In contrast, although R-Ras has been reported to bind Raf and Ral-GEF in a GTP-dependent fashion, the binding anities to these molecules are much lower than those of Ras (Herrmann et al., 1996; Nancy et al., 1999) . Corresponding with this, R-Ras causes only a marginal increase in the activity of ERK, a down- Figure 4 Eect of R-Ras Q87L on myoblast migration. C2-RRas(L3) cells were precultured in the growth medium with or without IPTG (5 mM) for 16 h. Then migration assay was performed as described in Materials and methods. Results represent the mean+s.e. of three independent trials stream molecule of Raf (Marte et al., 1997; Suzuki et al., 1997) and fails to activate Ral, a downstream molecule of Ral-GEF (Urano et al., 1996) . Thus, it seems that R-Ras cannot activate Raf or Ral-GEF. On the other hand, it has already been shown that R-Ras binds to and activates PI3K, and induces activation of Akt (Marte et al., 1997; Suzuki et al., 1998). We therefore conclude that the reason why only R-Ras can function as a promoter of skeletal myogenesis among Ras-family proteins is that R-Ras can activate mainly the PI3K pathway, which is necessary for myogenesis, but not the Raf and Ral-GEF pathways, which inhibit myoblast dierentiation. Figure 5 Possible involvement of R-Ras in skeletal myogenesis. (a) R-Ras expression in a series of cell lines: dierentiating L6 (rat myoblast), dierentiating C2C12 (mouse myoblast), Swiss3T3 (mouse ®broblast), NIH3T3 (mouse ®broblast), HT-1080 (human ®brosarcoma), COS (monkey kidney cell), HEK293 (human embryonal kidney cell), DLD-1 (human colon adenocarcinoma), 32D (mouse myeloid progenitor cell), BaF3 (mouse pro-B cell), SHSY-5Y (human neuroblastoma), and PC-12 (rat pheochromocytoma). Cell extract (40 mg) was subjected to SDS ± PAGE (15%), followed by Western blotting analysis using anti-R-Ras antibody. (b) RRas activation in dierentiating myoblasts. C2C12 cells were cultured in the dierentiation medium for the indicated periods. Cells were lysed and the amount of R-Ras´GTP was determined by R-Ras´GTP precipitation assay as described in Materials and methods. An arrow indicates the band of precipitated R-Ras´GTP. (c) Increase of R-Ras expression during dierentiation. Subcon¯uent C2C12 cells were incubated in the dierentiation medium for the indicated periods and lysed. Western blotting analysis was performed with anti-R-Ras antibody. (d) Eect of R-Ras GAP on induction of creatine kinase. C2C12 cells (2.5610 5 cells/35 mm collagen-coated dish) were cultured for 12 h in the growth medium and transfected with pOPRSV1 or pOPRSV1-R-ras GAP. One day later, cells were switched to the dierentiating condition and cultured further for 4 days. Cells were then lysed, and creatine kinase activity per dish was determined. Results are presented as percentage of the value of the mock transfection with pOPRSV1. Values represent the mean and standard error of three independent experiments It has been shown that a portion of myoblasts undergo cell death when induced to dierentiate by mitogen deprivation (Fimia et al., 1996; Wang and Walsh, 1996; Wang et al., 1997) . The present study demonstrates that R-Ras inhibits myoblast cell death. In C2C12 cells, R-Ras induces activation of Akt and enhanced expression of Bcl-x L (Figure 3) . Furthermore, it has been reported that expression of activated Akt or Bcl-2, displaying a biological function similar to Bcl-x L , rescues C2C12 cells from apoptosis (Dominov et al., 1998; Fujio et al., 1999) . Thus, it is likly that R-Ras provides myoblasts with resistance to apoptosis through Akt activation and Bcl-x L expression. Since myogenic dierentiation accompanies Akt activation (Fujio et al., 1999) and Bcl-x L expression (Figure 3d) , it remains to be clari®ed whether the activation of endogenous R-Ras indeed mediates these phenomena.
In addition to its eect on promoting survival of the dierentiating cells, R-Ras was also found to increase the eciency of myoblast fusion. Since migration of C2C12 cells was stimulated by induction of an activated form of R-Ras (Figure 4 ), R-Ras may stimulate fusion of myoblasts through increased motility by raising the frequency of cell ± cell adhesion and/or the eciency of cell alignment. Indeed, it has been reported that myotube formation can be inhibited by loss of integrin function, which is indispensable for myoblast migration (Menko and Boettinger, 1987; Rosen et al., 1992; Yao et al., 1996; Crawley et al., 1997; Rohwedel et al., 1998) .
As shown in Figure 5b , R-Ras activation was detected 1 day after C2C12 cells were changed to the dierentiation medium and reached its maximum after 2 days. However, the amount of R-Ras´GTP was reduced after 3 days in the dierentiation medium, when the fusion of myoblasts started. Thus, it is likely that C2C12 cells require the activation of R-Ras before the initiation of fusion. Since myoblasts undergo apoptosis only before the initiation of fusion (Wang and Walsh, 1996) and require their motility for fusion, the transient activation of R-Ras prior to the onset of fusion supports our idea that the roles of R-Ras in the myogenic dierentiation of C2C12 cells are to prevent apoptosis of dierentiating cells and to promote their motility.
In this study, we demonstrated that R-Ras may be involved in the program of skeletal myogenesis. This is supported by the observations that R-Ras is highly expressed in myoblast and that its expression is augmented on myogenic dierentiation, as well as by data on R-Ras activation during terminal dierentiation and the inhibitory eect of R-Ras GAP on dierentiation. Though we cannot substantiate, for certain, the role of R-Ras in myogenesis in vivo at the present stage, one can assume that R-Ras may prevent cell death and stimulate locomotion on muscle dierentiation during embryogenesis and tissue regeneration. It has been reported that myogenesis is accompanied by cell death of myoblasts in vivo (McClearn et al., 1995) . R-Ras thus may maintain survival of muscle precursor cells, which are more sensitive to apoptosis than terminally dierentiated myotubes, during myogenesis. During limb outgrowth, muscle precursor cells migrate from somites to limb buds, where they dierentiate into myotubes (Stockdale, 1992) . This process is modulated by several growth factors such as ®broblast growth factors and hepatocyte growth factor (Bladt et al., 1995; Itoh et al., 1996) . Therefore, it would be interesting if these growth factors could activate RRas to promote migration of myoblasts.
Materials and methods
Materials
Plasmid pOPRSV1-R-ras Q87L was generated from pUC12-Rras, a generous gift from DV Goeddel (Genentech Inc., South San Francisco, CA, USA), as described previously (Suzuki et al., 1998 ). Construction of pOPRSV1-H-ras G12V was described elsewhere (Edamatsu et al., 1998) . Plasmids pOPRSV1-R-ras GAP and pGEX-2T-PI3K-RBD (Kinoshita et al., 1997) were kindly provided by M Kobayashi and S Iwashita (Mitsubishi Kasei Institute of Life Sciences, Tokyo, Japan), and by M Shirouzu, S Yokoyama (RIKEN, Saitama, Japan), and Y Fukui (University of Tokyo, Tokyo, Japan), respectively. We purchased anti-R-Ras antibody (#15626E) and anti-myogenin antibody (#65121A) from Pharmingen 
Cell culture and transfection
C2C12 cells were grown in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 15% (v/v) fetal bovine serum (`growth medium'). Dierentiation was induced by culturing C2C12 cells in DMEM supplemented with 2% (v/v) horse serum (`dierentiation medium').
For stable transfection, pOPRSV1-R-ras Q87L or pOPRSV1-H-ras G12V was introduced into C2C12 cells with p3'SS (Stratagene, La Jolla, CA, USA) using Lipofectamine (Life Technologies, Inc., Rockville, MD, USA). One day after transfection, transfectants were isolated in the growth medium containing 400 mg/ml G418 and 200 mg/ml hygromycin. For transient transfection, pOPRSV1 or pOPRSV1-Rras GAP was transfected into subcon¯uent C2C12 cells on a collagen-coated dish with Lipofectamine and Lipofectamine PLUS (Life Technologies, Inc.). One day following transfection, the growth medium was replaced with the dierentiation medium, and cells were further cultured for 4 days. Cell lysate was prepared as described previously (Suzuki et al., 1998) .
R-Ras´GTP precipitation assay
Lysates (1.5 mg) were incubated for 1 h at 48C with 20 ml of Glutathione Sepharose 4B beads (Amersham Pharmacia Biotech Inc., Uppsala, Sweden) and 10 mg of GST-PI3K-RBD, which was produced in Escherichia coli and puri®ed with Glutathione Sepharose 4B beads according to the manufacturer's procedure. Then, beads were washed three times in 20 mM HEPES-NaOH (pH 7.4), 150 mM NaCl, 0.25% Triton X-100, 5 mM MgCl 2 , and boiled in the sample buer for SDS ± PAGE. Samples were resolved by SDS ± PAGE (15%).
Migration assay
Prior to the experiments, FALCON cell culture inserts (Becton Dickinson Labware, Franklin Lakes, NJ, USA) were coated with E-C-L Cell Attachment Matrix (Upstate Biotechnology Inc.). Trypsinized cells were washed once with the growth medium and suspended in DMEM containing 0.1% bovine serum albumin (BSA) at 1610 5 cell/ml. DMEM containing 0.1% BSA (750 ml) was added into a FALCON TC companion plate (24 well) (Becton Dickinson Labware). Immediately after the cell culture inserts were placed on the companion plate, the cell suspensions (500 ml) were added to the inserts. Samples were then incubated for 4 h at 378C, 10% CO 2 atmosphere. After incubation, the non-migrated cells were wiped away from the upper surface of the membrane of the insert, and the migrated cells on the lower surface of the membrane were stained with Di-Quik (International Reagents Corp., Kobe, Japan). The number of stained cells was counted in ®ve microscope ®elds.
